Bruce Strober, MD, PhD, from the United States, will begin his term as President of The International Psoriasis Council (IPC), which will last from 2025 to 2026.
Claudia de la Cruz, MD, from Chile, has been elected as Vice President/President-Elect; Catherine Smith, MD, from the United Kingdom, has been elected as Secretary; and Joel Gelfand, MD, PhD, from the United States, will continue to serve as Treasurer.
Hervé Bachelez, MD, PhD, from France, will also serve as the Immediate Past President for one more year.
More on the new Board Members
Yale University and Central Connecticut Dermatology
Cromwell, Connecticut, United States
President
Clinica Dermacross
Santiago, Chile
Vice President/President-Elect
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Treasurer
St John’s Institute of Dermatology, Guys and St Thomas’ Hospitals
London, United Kingdom
Secretary
Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, Paris Cité University
Paris, France
Immediate Past President
The 2025 IPC Fellows
IPC international fellows are matched with IPC Board Members or Councilors to observe and participate in clinical practice and laboratory research of patients with psoriasis. The 2025 IPC International Fellowship Program is supported in part by Bristol Myers Squibb.
Ryhov County Hospital, Dermatology Clinic
Jönköping, Sweden
Università di Modena and Reggio Emilia
Modena and Reggio Emilia, Italy
Temple University Hospital
Philadelphia,PA
Dina ElDisouki, MD
Cutis “The Skin Clinic”
Cairo, Egypt
2025 Fellow
Jennifer Lavina Ngo, MD-MBA, FPDS
Rizal Medical Center
Pasig,Philippines
St John’s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King’s College London,
London, United Kingdom
Kamenge Military Hospital
Bujumbura, Burundi
Universidade Catolica de Pelotas
Pelotas, Brazil
Applications for the 2026 fellowships will be accepted from September 1 to 30, 2025.
